(中国医科大学附属第一医院 李文扬 摘译 杨冬 审校)
(Bourdin al. Eur Respir J. 2019 Aug 29.)

ERS/EAACI Statement on severe exacerbations in asthma in adult: facts, priorities and key research questions.

Bourdin al. Eur Respir J. 2019 Aug 29.
Despite the use of effective medications to control asthma, severe exacerbations in asthma are still a major health risk and require urgent action on the part of the patient and physician to prevent a serious outcome such as hospitalisation or death. Moreover, severe exacerbations are associated with substantial huge healthcare costs, and psychological burden including anxiety and fear for patients and their families. The European Academy of Allergy and Clinical Immunology (EAACI) and the European Respiratory Society (ERS) set up a Task Force (TF) to search for a clear definition of severe exacerbations and to also define research questions and priorities. The statement includes comments from patients who were members of the TF.

上一篇: 全球哮喘防治创议(GINA): 25年后(Eur Respir J)
下一篇: 重度哮喘患者共患病的经济负担:一项20年的基于人群的研究